Target intelligence / Profile preview

L-type and N-type voltage-gated calcium channels (L/N-type VGCC)

Target
L/N-type VGCC
Molecular classification
Ion channel, Voltage-gated ion channel, Calcium channel
01

Overview

L-type and N-type high-voltage-activated calcium channels are critical components of the voltage-gated calcium channel (VGCC) family, serving as key regulators of calcium entry in excitable cells (Wikipedia, 2024). L-type channels (CaV1.1–CaV1.4) are primarily found in cardiac and smooth muscle, where they mediate excitation-contraction coupling, and in endocrine cells, where they regulate hormone secretion such as aldosterone (NIH, 2024). N-type channels (CaV2.2) are predominantly localized at presynaptic nerve terminals, where they trigger the release of neurotransmitters like norepinephrine and play a vital role in pain transmission and sympathetic nervous system activity (PubMed, 2019). Drugs that act as dual L/N-type blockers, such as cilnidipine, are utilized in the management of hypertension, offering advantages over L-type-selective blockers by suppressing sympathetic reflex activity and providing renoprotective effects through the dilation of both afferent and efferent renal arterioles (JAPI, 2024). These channels are also significant targets in the treatment of chronic pain and are being investigated for their roles in neurodegenerative and neuropsychiatric disorders (NIH, 2022). Structurally, these channels are heteromultimeric complexes consisting of a pore-forming alpha-1 subunit and auxiliary subunits that modulate channel kinetics and trafficking (StatPearls, 2023).

Other names
L-type calcium channelsN-type calcium channelsL/N-type calcium channel blocker targetHigh-voltage-activated calcium channelsHVA calcium channelsCaV1 and CaV2.2 channels
02

Mechanism of action

Blockade of the alpha-1 subunit of both L-type and N-type voltage-gated calcium channels, inhibiting the influx of calcium ions into cells.

03

Biological functions

Muscle contractionNeurotransmitter releaseCalcium signalingSympathetic nerve regulationAldosterone secretion
04

Disease associations

HypertensionChronic kidney diseaseNeuropathic painCardiovascular diseaseCardiac arrhythmia
05

Safety considerations

HypotensionBradycardiaDizzinessHeadacheFlushingPeripheral edema
06

Interacting drugs

Cilnidipine

4 more in the full profile.

07

Biomarkers

Blood pressureHeart rateUrinary albumin-to-creatinine ratioPlasma aldosterone concentrationPlasma renin activity

Beyond the preview

Go deeper on L-type and N-type voltage-gated calcium channels (L/N-type VGCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-type and N-type voltage-gated calcium channels (L/N-type VGCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call